|Values are valid only on day of printing.|
Evaluating patients who have failed therapy with selective serotonin reuptake inhibitors (SSRIs)
Evaluating patients with treatment-resistant depression
Predicting response time to improvement with SSRIs
Identifying patients who might respond favorably to a class of antidepressants other than SSRI.
Identifying patients who have diminished amounts of the serotonin transporter and, hence, an altered response to SSRI therapeutics
Polymerase Chain Reaction (PCR) Followed by Sizing Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)